[Federal Register Volume 63, Number 38 (Thursday, February 26, 1998)]
[Notices]
[Pages 9846-9847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-4881]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act
(FACA), as amended (5 U.S.C. Appendix 2) notice is hereby given of the
advisory committee meetings listed below of the National Cancer
Institute (NCI).
[[Page 9847]]
The meetings will be open to the public as indicated below, with
attendance by the public limited to space available. Individuals who
plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should contact Ms.
Linda Quick-Cameron, Committee Management Officer, at (301) 496-5708,
in advance of the meetings.
A portion of the meetings will be closed to the public in
accordance with the provisions set forth in sections 552b(c)(4),
552b(c)(6), and 552b(c)(9)(B), Title 5 U.S.C., and section 10(d) of the
FACA, for the review, discussion and evaluation of individual programs
and for discussion of issues pertaining to programmatic areas and/or
NCI personnel. These discussions could reveal confidential trade
secrets or commercial property such as patentable material, and
personal information concerning the individuals associated with the
programs, including consideration of personnel qualifications and
performances, the competence of individual investigators and similar
matters, the disclosure of which would constitute a clearly unwarranted
invasion of personal privacy and premature disclosure of
recommendations which would likely significantly frustrate the
subsequent implementation of recommendations.
The Committee Management Office, National Cancer Institute,
National Institutes of Health, Executive Plaza North, Room 609, 6130
Executive Boulevard, MSC 7410, Rockville, Maryland 20892-7410, (301)
496-5708, will provide summaries of the meetings and rosters of the
committee members, upon request.
Name of Committee: Advisory Committee to the Director, National
Cancer Institute.
Contact Person: Susan J. Waldrop, Executive Secretary, National
Cancer Institute, NIH, Federal Building, Room 312, Bethesda, MD
20892, (301) 496-1458.
Date of Meeting: March 1, 1998.
Place of Meeting: Hyatt Regency--Bethesda, One Bethesda Metro
Center, Congressional Room, Bethesda, MD 20814.
Open: 7 p.m. to Adjournment.
Agenda: To update the Committee on the activities of the NCI
Working Groups and on the groups reporting to the Advisory Committee
to the Director, NCI.
Committee Name: Joint Meeting--National Cancer Institute Board
of Scientific Advisors and Board of Scientific Counselors, National
Cancer Institute.
Date: March 2, 1998.
Place: Building 31C, 6th Floor, Conference Room 10, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Open: 8 a.m. to 9:20 a.m.
Agenda: Report of the Director, NCI.
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, 20892-7405, (301) 496-
4218.
Committee Name: National Cancer Institute Board of Scientific
Advisors.
Date: March 2-3, 1998.
Place: Building 31C, 6th Floor, Conference Room 10, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Open: March 2-9:30 a.m. to Recess; March 3-8 a.m. to
Adjournment.
Agenda: RFA Concept Reviews, Report of the Deputy Director for
Extramural Science, Status Reports of Implementing Program, Review
Group(s) Recommendations, Budget Presentation and Status Reports
from the Extramural Divisions.
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
4218.
Committee Name: Joint Meeting--Board of Scientific Counselors,
National Cancer Institute, Clinical Sciences and Epidemiology--
Subcommittee A, Basic Sciences--Subcommittee B.
Date: March 2, 1998.
Place: Building 31C, 6th Floor, Conference Room 10, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Closed: 9:20 a.m.-10:15 a.m.
Agenda: Discussion of Intramural Review Issues.
Contact Person: Florence Farber, Ph.D., Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 643G,
6130 Executive Blvd., MSC 7410, Bethesda, MD 20892-7410, (301) 496-
2378.
Committee Name: Board of Scientific Counselors, National Cancer
Institute, Clinical Sciences and Epidemiology--Subcommittee A.
Date: March 2, 1998.
Place: Building 31C, 6th Floor, Conference Room 6, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Closed: 10:30 a.m. to Adjournment.
Agenda: To discuss administrative confidential matters
pertaining to the Division of Clinical Sciences and the Division of
Cancer Epidemiology and Genetics.
Contact Person: Judy Mietz, Ph.D., Executive Secretary, National
Cancer Institute, NIH, Executive Plaza North, Room 600, 6130
Executive Blvd., MCS 7410, Bethesda, MD 20892-7410, (301) 496-2378.
Committee Name: Board of Scientific Counselors, National Cancer
Institute Basic Sciences--Subcommittee B.
Date: March 2, 1998.
Place: Building 31C, 6th Floor, Conference Room 8, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Closed: 10:30 a.m. to Adjournment.
Agenda: To discuss administrative confidential matters and site
visit reports pertaining to the laboratories in the Division of
Basic Sciences.
Contact Person: Florence Farber, Ph.D., Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 643G,
6130 Executive Blvd., MSC 7410, Bethesda, MD 20892-7410, (301) 496-
2378.
This notice is being published less than 15 days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the review and funding cycle.
(Catalog of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control)
Dated: February 17, 1998.
LaVeen Ponds,
Acting Committee Management Officer, National Institutes of Heath.
[FR Doc. 98-4881 Filed 2-25-98; 8:45 am]
BILLING CODE 4140-01-M